However, the activation of the VEGF pathway by dihydroartemisinin, along with its regulation of the PI3K/AKT/mTOR/ULK1 pathway, facilitates autophagy and retards the progression of NAFLD (171). Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.